Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'

被引:37
作者
Lip, GYH [1 ]
Blann, AD [1 ]
机构
[1] Univ Birmingham, Dept Med, City Hosp, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
angiogenesis; atherogenesis; thrombogenesis; vascular disease;
D O I
10.1080/07853890310021607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amongst the components of the pathophysiology of atherosclerosis are the tendency to thrombus formation (i.e., thrombogenesis) and the loss of endothelial cell integrity The endothelium is also implicated in atherogenesis, as vasal vasorum are present in the adventitia and media at a higher density in atherosclerotic tissue, and that neovascularisation leading to collateral growth bypassing obstruction and/or stenoses provides important alternative routes to feeding distal tissues. The development of these new blood vessels is the process of angiogenesis. The present 'viewpoint' article will explore the relationships between the three processes. There is considerable evidence that atherogenesis and thrombogenesis are intimately linked, but angiogenesis in cardiovascular disease is a recently developed concept. We propose a new 'vascular triad' of these abnormal pathophysiological processes, leading to an alternative view of the pathogenesis of vascular disease. Indeed, we suggest that angiogenesis is an important aspect of the pathophysiology of cardiovascular disease, impacting with both thrombogenesis and atherogenesis, in a new vascular triad (the 'Birmingham vascular triad').
引用
收藏
页码:119 / 125
页数:7
相关论文
共 58 条
[1]   Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor [J].
Abe, K ;
Shoji, M ;
Chen, J ;
Bierhaus, A ;
Danave, I ;
Micko, C ;
Casper, K ;
Dillehay, DL ;
Nawroth, PP ;
Rickles, FR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8663-8668
[2]  
Alber HF, 2002, J AM COLL CARDIOL, V39, P1951
[3]   Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology [J].
Banks, RE ;
Forbes, MA ;
Kinsey, SE ;
Stanley, A ;
Ingham, E ;
Walters, C ;
Selby, PJ .
BRITISH JOURNAL OF CANCER, 1998, 77 (06) :956-964
[4]  
BARER AC, 1984, NEW ENGL J MED, V310, P175
[5]  
BATTEGAY EJ, 1995, J MOL MED, V73, P333
[6]  
BELGORE F, 2003, IN PRESS J CLIN PATH
[7]   Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension [J].
Belgore, FM ;
Blann, AD ;
Li-Saw-Hee, FL ;
Beevers, DG ;
Lip, GYH .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06) :805-+
[8]   Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls [J].
Blann, AD ;
Amiral, J ;
McCollum, CN ;
Lip, GYH .
ATHEROSCLEROSIS, 2000, 152 (01) :29-34
[9]   Virchow's triad revisited: The importance of soluble coagulation factors, the endothelium, and platelets [J].
Blann, AD ;
Lip, GYH .
THROMBOSIS RESEARCH, 2001, 101 (04) :321-327
[10]   Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of Fluvastatin or Fenofibrate [J].
Blann, AD ;
Belgore, FM ;
Constans, J ;
Conri, C ;
Lip, GYP .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (10) :1160-1163